CJC-1295 · Ipamorelin

Growth Hormone · 10 mg fill · Research Peptide

A no-DAC GHRH analog paired with a selective secretagogue, investigated for endogenous GH rhythm.

Overview

This research blend combines CJC-1295 in its no-DAC (modified GRF 1–29) short-acting form with Ipamorelin, a selective growth-hormone secretagogue. The pairing is studied in models of pulsatile growth-hormone release and somatotropic-axis signaling.

Specifications

Composition

CJC-1295 no-DAC (mod. GRF 1–29) 5 mg + Ipamorelin 5 mg

Form

Lyophilized blend

Vial Size

10 mg (combined)

Purity

Stated on the lot COA

Reconstitution

Bacteriostatic water

Storage

−20°C · protect from light

Documentation

Batch-specific COA

Research applications

• Pulsatile GH-release research
• Somatotropic-axis signaling models
• Combination-peptide synergy studies
• Receptor-selectivity research

For research use only. This product is intended for laboratory and educational research purposes only. It is not made, labelled or sold as a drug, supplement or medical device, and it is not for human or veterinary consumption, diagnosis, treatment or cure of any condition.

Adds it to your order request in the catalog.